Tag: ADVANZ PHARMA acquisition

ADVANZ PHARMA to acquire Alprostadil products from UCB S.A. for $84 mn

ADVANZ PHARMA Corp. Limited, a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, announced it signed a definitive agreement to acquire the rights to a portfolio of alprostadil products in 10 European Union countries, as well as the United…